Immunotherapy for Early-Stage Resectable NSCLC: Optimizing Multidisciplinary Management Today

Immunotherapy for Early-Stage Resectable NSCLC: Optimizing Multidisciplinary Management Today

The goal of this activity is for learners to be better able to manage patients with early-stage resectable NSCLC with available immunotherapy treatment strategies.

  • Provider:Medscape, LLC
  • Activity Link: https://www.medscape.org/viewarticle/1001332
  • Start Date: 2024-07-15 05:00:00
  • End Date: 2024-07-15 05:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
  • MOC Credit Details: ABIM - 0.5 Point; Credit Type(s): Medical Knowledge (ABIM)
  • Commercial Support: Source: F. Hoffman La Roche Ltd - Amount: 140365.0 - Is Kind Support: False
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Knowledge, Learner/Team Competence
  • Provider Ship: Directly Provided
  • Registration: Open to all
  • Specialty: Medical Oncology
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.